• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.

作者信息

Borsi L, Carnemolla B, Nicolò G, Spina B, Tanara G, Zardi L

机构信息

Laboratory of Cell Biology, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

出版信息

Int J Cancer. 1992 Nov 11;52(5):688-92. doi: 10.1002/ijc.2910520504.

DOI:10.1002/ijc.2910520504
PMID:1385335
Abstract

Functionally different tenascin (TN) isoforms, containing varying numbers of a 91 amino-acid motif resembling the fibronectin type-III homology repeat, may be generated by alternative splicing of the TN primary transcript. In fact, only the TN isoform containing the alternatively spliced region can induce loss of focal adhesion in cultured cells and seems to be able to facilitate cell migration. We examined the patterns of alternative splicing of the TN primary transcript in normal, hyperplastic and neoplastic breast tissues, and found that, in all the invasive breast carcinomas analyzed, the relative amount of TN mRNA in which the alternatively spliced region was included was about 10 times higher than in RNA from normal breast tissues. A similar result was observed in phyllodes tumors and in those fibroadenomas which showed very high stromal cellularity. Western-blot analysis using different monoclonal antibodies showed the same pattern as that seen in Northern blotting. The data reported here suggest that, in the breast, expression of the high-molecular-mass TN isoform is a marker of stromal element proliferation and that, in invasive breast carcinomas, this TN isoform could play a role in generating a permissive environment for proliferation, invasion and metastasis of neoplastic epithelial cells.

摘要

相似文献

1
Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Int J Cancer. 1992 Nov 11;52(5):688-92. doi: 10.1002/ijc.2910520504.
2
Cell-cycle dependent alternative splicing of the tenascin primary transcript.腱生蛋白初级转录本的细胞周期依赖性可变剪接。
Cell Adhes Commun. 1994 Jan;1(4):307-17. doi: 10.3109/15419069409097262.
3
Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression.
Perspect Dev Neurobiol. 1994;2(1):117-23.
4
Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies.人腱生蛋白:一级结构、前体mRNA剪接模式以及两种单克隆抗体识别的表位定位
Nucleic Acids Res. 1991 Feb 11;19(3):525-31. doi: 10.1093/nar/19.3.525.
5
Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.人腱生蛋白在转化肺成纤维细胞和肺肿瘤组织中的定性和定量变化:与纤连蛋白的比较
Cancer Res. 1991 Sep 15;51(18):4876-81.
6
TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung.转化生长因子-β调节胎鼠肺中肌腱蛋白可变剪接异构体的表达。
Am J Physiol. 1995 Feb;268(2 Pt 1):L173-80. doi: 10.1152/ajplung.1995.268.2.L173.
7
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.浸润性和癌前乳腺疾病中肌腱蛋白-C异构体表达的变化
Cancer Res. 2002 Jun 1;62(11):3289-97.
8
Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.小鼠腱生蛋白:cDNA克隆、异构体的结构及时间表达
Gene. 1991 Aug 15;104(2):177-85. doi: 10.1016/0378-1119(91)90248-a.
9
The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.腱生蛋白-X的分布是独特的,且常常与腱生蛋白-C的分布相反。
J Cell Biol. 1994 Apr;125(2):483-93. doi: 10.1083/jcb.125.2.483.
10
Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.人源小、大腱生蛋白-C 异构体对基质金属蛋白酶降解的不同敏感性。
J Biol Chem. 1995 Apr 14;270(15):8650-4. doi: 10.1074/jbc.270.15.8650.

引用本文的文献

1
RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications.癌症中的RNA表观遗传学:当前认知与治疗意义
MedComm (2020). 2025 Aug 3;6(8):e70322. doi: 10.1002/mco2.70322. eCollection 2025 Aug.
2
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein.乌帕替尼联合治疗可消除肿瘤靶向性白细胞介素-2融合蛋白的全身毒性。
J Immunother Cancer. 2025 May 11;13(5):e010831. doi: 10.1136/jitc-2024-010831.
3
RNA splicing dysregulation and the hallmarks of cancer.RNA 剪接失调与癌症的特征。
Nat Rev Cancer. 2023 Mar;23(3):135-155. doi: 10.1038/s41568-022-00541-7. Epub 2023 Jan 10.
4
Revisiting the Tenascins: Exploitable as Cancer Targets?重新审视腱糖蛋白:可用作癌症靶点吗?
Front Oncol. 2022 Jun 17;12:908247. doi: 10.3389/fonc.2022.908247. eCollection 2022.
5
The Functional Role of Extracellular Matrix Proteins in Cancer.细胞外基质蛋白在癌症中的功能作用
Cancers (Basel). 2022 Jan 4;14(1):238. doi: 10.3390/cancers14010238.
6
Utilizing Immunocytokines for Cancer Therapy.利用免疫细胞因子进行癌症治疗。
Antibodies (Basel). 2021 Mar 9;10(1):10. doi: 10.3390/antib10010010.
7
Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.肿瘤相关巨噬细胞通过分泌转化生长因子β诱导(TGFBI)和 tenascin C 促进卵巢癌细胞迁移。
Cell Death Dis. 2020 Apr 20;11(4):249. doi: 10.1038/s41419-020-2438-8.
8
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.癌症中的可变剪接缺陷:剪接调控因子及其下游靶点,为新型癌症治疗方法指明方向。
Wiley Interdiscip Rev RNA. 2018 Jul;9(4):e1476. doi: 10.1002/wrna.1476. Epub 2018 Apr 25.
9
A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo.基于蒽环类药物有效载荷的非内化抗体药物偶联物在体内显示出强大的治疗活性。
J Control Release. 2017 Oct 28;264:211-218. doi: 10.1016/j.jconrel.2017.08.040. Epub 2017 Sep 1.
10
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma.在临床上不同亚型的浸润性导管癌中广泛存在的选择性外显子使用。
Sci Rep. 2017 Jul 17;7(1):5568. doi: 10.1038/s41598-017-05537-0.